Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) (GOLD 2023) maintains the basic framework of GOLD 2022, but with major revisions in the definition, assessment, initial therapy and follow-up management of chronic obstructive lung di...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese General Practice Publishing House Co., Ltd
2023-04-01
|
| Series: | Zhongguo quanke yixue |
| Subjects: | |
| Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/zx20230052.pdf |
| _version_ | 1797216746828988416 |
|---|---|
| author | LIANG Zhenyu, WANG Fengyan, CHEN Zizheng, CHEN Rongchang |
| author_facet | LIANG Zhenyu, WANG Fengyan, CHEN Zizheng, CHEN Rongchang |
| author_sort | LIANG Zhenyu, WANG Fengyan, CHEN Zizheng, CHEN Rongchang |
| collection | DOAJ |
| description | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) (GOLD 2023) maintains the basic framework of GOLD 2022, but with major revisions in the definition, assessment, initial therapy and follow-up management of chronic obstructive lung disease (COPD) as follow: (1) Chapter 1: The definition and overview section was rewritten to propose a new definition of COPD, incorporating new background information, therapeutic strategies and classifications for COPD, with the addition of content on chronic bronchitis; (2) Chapter 2: Content on screening and case-finding of COPD has been included, the ABCD assessment tool has been revised to the ABE assessment tool (no further grouping of high-risk population of acute exacerbation of COPD based on symptom levels), information on imaging and computed tomography scans (CT) has been included in the diagnosis and assessment section; (3) Chapter 3: Recommendations for Streptococcus pneumoniae vaccination have been updated, information on therapeutic interventions to reduce COPD mortality has been included, issues related to inhalation delivery have been updated, content on inhaled medications adherence and remote rehabilitation has been included, information on interventional and surgical therapies of COPD has been expanded in the prevention and maintenance treatment section; (4) Chapter 4: Information on the selection of inhalation devices has been included, information on initial drug therapy and follow-up drug therapy has been updated in the management of stable COPD section; (5) Chapter 5: A new definition of and set of acute exacerbation of COPD assessment parameters have been proposed, information on differential diagnoses of acute exacerbation of COPD has been expanded in the acute exacerbation of COPD section management; (6) Chapter 6 and 7: Updating content on COPD and complications (Chapter 6), COPD (Chapter 7) and COVID-19 based on the latest evidence. The above updates will be an important guide to the clinical management of COPD. |
| first_indexed | 2024-04-24T11:50:52Z |
| format | Article |
| id | doaj.art-1c3b7a5fdbfc4bae8fe4c1cb231745ae |
| institution | Directory Open Access Journal |
| issn | 1007-9572 |
| language | zho |
| last_indexed | 2024-04-24T11:50:52Z |
| publishDate | 2023-04-01 |
| publisher | Chinese General Practice Publishing House Co., Ltd |
| record_format | Article |
| series | Zhongguo quanke yixue |
| spelling | doaj.art-1c3b7a5fdbfc4bae8fe4c1cb231745ae2024-04-09T07:44:34ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722023-04-0126111287129810.12114/j.issn.1007-9572.2023.0052Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report)LIANG Zhenyu, WANG Fengyan, CHEN Zizheng, CHEN Rongchang01. The First Affiliated Hospital of Guangzhou Medical University/Guangzhou Institute of Respiratory Health, Department of Pulmonary and Critical Care Medicine/National Center for Respiratory Medicine/National Clinical Research Center for Respiratory Disease/State Key Laboratory of Respiratory Disease, Guangzhou 510120, China;2. Department of Pulmonary and Critical Care Medicine, Shenzhen People's Hospital/Shenzhen Institute of Respiratory Disease, Shenzhen 518020, ChinaGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) (GOLD 2023) maintains the basic framework of GOLD 2022, but with major revisions in the definition, assessment, initial therapy and follow-up management of chronic obstructive lung disease (COPD) as follow: (1) Chapter 1: The definition and overview section was rewritten to propose a new definition of COPD, incorporating new background information, therapeutic strategies and classifications for COPD, with the addition of content on chronic bronchitis; (2) Chapter 2: Content on screening and case-finding of COPD has been included, the ABCD assessment tool has been revised to the ABE assessment tool (no further grouping of high-risk population of acute exacerbation of COPD based on symptom levels), information on imaging and computed tomography scans (CT) has been included in the diagnosis and assessment section; (3) Chapter 3: Recommendations for Streptococcus pneumoniae vaccination have been updated, information on therapeutic interventions to reduce COPD mortality has been included, issues related to inhalation delivery have been updated, content on inhaled medications adherence and remote rehabilitation has been included, information on interventional and surgical therapies of COPD has been expanded in the prevention and maintenance treatment section; (4) Chapter 4: Information on the selection of inhalation devices has been included, information on initial drug therapy and follow-up drug therapy has been updated in the management of stable COPD section; (5) Chapter 5: A new definition of and set of acute exacerbation of COPD assessment parameters have been proposed, information on differential diagnoses of acute exacerbation of COPD has been expanded in the acute exacerbation of COPD section management; (6) Chapter 6 and 7: Updating content on COPD and complications (Chapter 6), COPD (Chapter 7) and COVID-19 based on the latest evidence. The above updates will be an important guide to the clinical management of COPD.https://www.chinagp.net/fileup/1007-9572/PDF/zx20230052.pdfpulmonary disease, chronic obstructive|global initiative for chronic obstructive lung disease|bronchitis, chronic|diagnostic screening programs|symptom assessment|therapy|inhalants|treatment adherence and compliance|acute exacerbation |
| spellingShingle | LIANG Zhenyu, WANG Fengyan, CHEN Zizheng, CHEN Rongchang Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) Zhongguo quanke yixue pulmonary disease, chronic obstructive|global initiative for chronic obstructive lung disease|bronchitis, chronic|diagnostic screening programs|symptom assessment|therapy|inhalants|treatment adherence and compliance|acute exacerbation |
| title | Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) |
| title_full | Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) |
| title_fullStr | Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) |
| title_full_unstemmed | Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) |
| title_short | Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) |
| title_sort | updated key points interpretation of global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease 2023 report |
| topic | pulmonary disease, chronic obstructive|global initiative for chronic obstructive lung disease|bronchitis, chronic|diagnostic screening programs|symptom assessment|therapy|inhalants|treatment adherence and compliance|acute exacerbation |
| url | https://www.chinagp.net/fileup/1007-9572/PDF/zx20230052.pdf |
| work_keys_str_mv | AT liangzhenyuwangfengyanchenzizhengchenrongchang updatedkeypointsinterpretationofglobalstrategyforthediagnosismanagementandpreventionofchronicobstructivepulmonarydisease2023report |